1-3 of 3
Yosifusa Takatsuka
Close
Sort by
Journal Articles

GvATLL Effect in the Relapse and Progression Cases After Hematopoietic Stem Cell Transplantation (HSCT) for Adult T-Cell Leukemia/Lymphoma (ATLL).

Nobuaki Nakano, MD, Ayumu Kubota, MD, Mayumi Tokunaga, MD, Masahito Tokunaga, MD, Shogo Takeuchi, MD, Yosifusa Takatsuka, MD, Atae Utsunomiya, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 4299.
https://doi.org/10.1182/blood.V114.22.4299.4299
Published: 2009
Journal Articles

Appropriate Patient Selection Before Allogenic Stem Cell Transplantation (allo-SCT) and Chronic GvHD After Allo-SCT Would Be Necessary for Better Outcome of Chemorefractory Non-Hodgkin's Lymphomas-A Single Institute Retrospective Study-.

Nobuaki Nakano, MD, Yosifusa Takatsuka, MD, Shogo Takeuchi, MD, Masahito Tokunaga, MD, Mayumi Tokunaga, MD, Ayumu Kubota, MD, Takahiro Itoyama, MD, Atae Utsunomiya, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 4302.
https://doi.org/10.1182/blood.V114.22.4302.4302
Published: 2009
Journal Articles

Clinical Significance of Serum TARC/CCL17 in ATLL Patients: High TARC/CCL17 Level Is a Significant Unfavorable Prognostic Factor

Atsushi Inagaki, Takashi Ishida, Hiroki Yano, Fumiko Mori, Asahi Ito, Masaki Ri, Jianmin Ding, Shigeru Kusumoto, Hirokazu Komatsu, Shinsuke Iida, Kentaro Yonekura, Shogo Takeuchi, Yosifusa Takatsuka, Atae Utsunomiya, Ryuzo Ueda
Journal: Blood
Blood (2008) 112 (11): 2821.
https://doi.org/10.1182/blood.V112.11.2821.2821
Published: 2008